Natalie L. Rasgon

Publications

• Insulin resistance and hyperlipidemia in women with bipolar disorder. Stemmle PG, Kenna HA, Wang PW, Hill SJ, Ketter TA, Rasgon NL. J Psychiatr Res. 2009; 43 (3): 341-3
• Relationship among latitude, climate, season and self-reported mood in bipolar disorder. Bauer M, Glenn T, Grof P, Rasgon NL, Marsh W, Sagduyu K, Alda M, Murray G, Quiroz D, Malliaris Y, Sasse J, Pilhatsch M, Whybrow PC. J Affect Disord. 2009; 116 (1-2): 152-7
• Comparison of sleep/wake parameters for self-monitoring bipolar disorder. Bauer M, Glenn T, Grof P, Rasgon N, Alda M, Marsh W, Sagduyu K, Schmid R, Adli M, Whybrow PC. J Affect Disord. 2009; 116 (3): 170-5
• Increased depressive symptoms in menopausal age women with bipolar disorder: age and gender comparison. Marsh WK, Ketter TA, Rasgon NL. J Psychiatr Res. 2009; 43 (8): 798-802
• Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. McIntyre RS, Rasgon NL, Kemp DE, Nguyen HT, Law CW, Taylor VH, Woldeyohannes HO, Alsuwaidan MT, Soczynska JK, Kim B, Lourenco MT, Kahn LS, Goldstein BI. Curr Diab Rep. 2009; 9 (1): 51-9
• Reproductive and metabolic abnormalities associated with bipolar disorder and its treatment. Kenna HA, Jiang B, Rasgon NL. Harv Rev Psychiatry. 2009; 17 (2): 138-46
• Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. Bauer M, Silverman DH, Schlagenhauf F, London ED, Geist CL, van Herle K, Rasgon N, Martinez D, Miller K, van Herle A, Berman SM, Phelps ME, Whybrow PC. J Clin Endocrinol Metab. 2009; 94 (8): 2922-9
• Genetic overlap between polycystic ovary syndrome and bipolar disorder: The endophenotype hypothesis. Jiang B, Kenna HA, Rasgon NL. Med Hypotheses. 2009
• Frequency of subsyndromal symptoms and employment status in patients with bipolar disorder. Bauer M, Glenn T, Grof P, Rasgon NL, Marsh W, Sagduyu K, Alda M, Lewitzka U, Sasse J, Kozuch-Krolik E, Whybrow PC. Soc Psychiatry Psychiatr Epidemiol. 2009; 44 (7): 515-22
• Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study. Wroolie TE, Kenna HA, Williams KE, Powers BN, Holcomb M, Lazzeroni L, Rasgon NL. Acta Neurol Scand. 2009; 119 (3): 172-9
• Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women. Morgan ML, Rapkin AJ, Biggio G, Serra M, Pisu MG, Rasgon N. Arch Womens Ment Health. 2009
• Thalamo-Basal Ganglia connectivity in postmenopausal women receiving estrogen therapy. Kenna HA, Rasgon NL, Geist C, Small G, Silverman D. Neurochem Res. 2009; 34 (2): 234-7
• Children of persons with Alzheimer disease: what does the future hold? Jarvik L, LaRue A, Blacker D, Gatz M, Kawas C, McArdle JJ, Morris JC, Mortimer JA, Ringman JM, Ercoli L, Freimer N, Gokhman I, Manly JJ, Plassman BL, Rasgon N, Roberts JS, Sunderland T, Swan GE, Wolf PA, Zonderman AB. Alzheimer Dis Assoc Disord. 2008 Jan-Mar; 22 (1): 6-20
• Changes in self-reported sleep duration predict mood changes in bipolar disorder. Bauer M, Glenn T, Whybrow PC, Grof P, Rasgon N, Alda M, Marsh W, Sagduyu K, Schmid R, Adli M. Psychol Med. 2008; 38 (7): 1069-71
• Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: preliminary report. Marsh WK, Templeton A, Ketter TA, Rasgon NL. J Psychiatr Res. 2008; 42 (3): 247-51
• Cerebral metabolic patterns in untreated postmenopausal women with major depressive disorder. Rasgon NL, Kenna HA, Geist C, Small G, Silverman D. Psychiatry Res. 2008; 164 (1): 77-80
• Self-reporting software for bipolar disorder: validation of ChronoRecord by patients with mania. Bauer M, Wilson T, Neuhaus K, Sasse J, Pfennig A, Lewitzka U, Grof P, Glenn T, Rasgon N, Bschor T, Whybrow PC. Psychiatry Res. 2008; 159 (3): 359-66
• Mood disorders and fertility in women: a critical review of the literature and implications for future research. Williams KE, Marsh WK, Rasgon NL. Hum Reprod Update. 2007 Nov-Dec; 13 (6): 607-16
• Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study. Rasgon NL, Dunkin J, Fairbanks L, Altshuler LL, Troung C, Elman S, Wroolie TE, Brunhuber MV, Rapkin A. J Psychiatr Res. 2007 Apr-Jun; 41 (3-4): 338-43
• Hypothalamic-pituitary-end organ function in women with bipolar depression. Rasgon NL, Kenna HA, Wong ML, Whybrow PC, Bauer M. Psychoneuroendocrinology. 2007; 32 (3): 279-86
• Self-reported data from patients with bipolar disorder: frequency of brief depression. Bauer M, Glenn T, Grof P, Pfennig A, Rasgon NL, Marsh W, Munoz RA, Sagduyu K, Alda M, Quiroz D, Sasse J, Whybrow PC. J Affect Disord. 2007; 101 (1-3): 227-33
• Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review. Reynolds MF, Sisk EC, Rasgon NL. Curr Med Chem. 2007; 14 (26): 2799-812
• Verbal memory retrieval deficits associated with untreated hypothyroidism. Miller KJ, Parsons TD, Whybrow PC, Van Herle K, Rasgon N, Van Herle A, Martinez D, Silverman DH, Bauer M. J Neuropsychiatry Clin Neurosci. 2007; 19 (2): 132-6
• A case of olanzapine-induced gestational diabetes mellitus in the absence of weight gain. Vemuri MP, Rasgon NL. J Clin Psychiatry. 2007; 68 (12): 1989
• Approximate entropy of self-reported mood prior to episodes in bipolar disorder. Glenn T, Whybrow PC, Rasgon N, Grof P, Alda M, Baethge C, Bauer M. Bipolar Disord. 2006; 8 (5 Pt 1): 424-9
• Estrogen replacement and cognition in postmenopausal women: Effects of years since menopause on response to treatment. Dunkin J, Rasgon N, Zeller M, Wagner-Steh K, David S, Altshuler L, Rapkin A. Drug Development Research. 2006: 66 150-159
• Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder. Bauer M, Rasgon N, Grof P, Glenn T, Marsh W, Munoz R, Suwalska A, Lapp M, Bschor T, Alda M, Whybrow P. European Psychiatry. 2006: 21 262-269
• Mood and neuropsychological changes in women with midlife depression treated with escitalopram. Wroolie TE, Williams KE, Keller J, Zappert LN, Shelton SD, Kenna HA, Reynolds MF, Rasgon NL. J Clin Psychopharmacol. 2006; 26 (4): 361-6
• Memory improvement with treatment of hypothyroidism. Miller KJ, Parsons TD, Whybrow PC, van Herle K, Rasgon N, van Herle A, Martinez D, Silverman DH, Bauer M. Int J Neurosci. 2006; 116 (8): 895-906
• Self-reported data from patients with bipolar disorder: impact on minimum episode length for hypomania. Bauer M, Grof P, Rasgon NL, Marsh W, Munoz RA, Sagduyu K, Alda M, Quiroz D, Glenn T, Baethge C, Whybrow PC. J Affect Disord. 2006; 96 (1-2): 101-5
• Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder. Bauer M, Rasgon N, Grof P, Glenn T, Lapp M, Marsh W, Munoz R, Suwalska A, Baethge C, Bschor T, Alda M, Whybrow PC. Eur Psychiatry. 2006; 21 (4): 262-9
• Reproductive health and bipolar disorder. Ketter TA, Suppes T, Morrell MJ, Rasgon N, Cohen LS, Viguera AC. CNS Spectr. 2006; 11 (5 Suppl 5): 1-16
• Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study. Binesh N, Huda A, Thomas MA, Wyckoff N, Bugbee M, Han S, Rasgon N, Davanzo P, Sayre J, Guze B, Martin P, Fawzy F. J Appl Clin Med Phys. 2006; 7 (1): 86-96
• Temporal relation between sleep and mood in patients with bipolar disorder. Bauer M, Grof P, Rasgon N, Bschor T, Glenn T, Whybrow PC. Bipolar Disord. 2006; 8 (2): 160-7
• Cannon-Spoor et al.'s Assessment. Rasgon N, Jarvik L. Am J Geriatr Psychiatry. 2006; 14 (3): 293
• Changes in regional brain metabolism and insulin resistance in postmenopausal women. Rasgon NL, Geist CL, Phelps ME, Silverman DHS. Journal of Nuclear Medicine. 2006; 47 (S1): 300P
• Gender Differences in Bipolar Disorder Templeton A, Rasgon N. Bipolar Case Review Quarterly. 2005: 1 3-6
• Use of polypharmacy and self-report mood in outpatients with bipolar disorder. Adli M, Whybrow PC, Grof P, Rasgon N, Gyulai L, Baethge C, Glenn T, Bauer M. International Journal of Psychiatry in Clinical Practice.. 2005; 9 (4): 251-256
• Mood changes related to antidepressants: a longitudinal study of patients with bipolar disorder in a naturalistic setting. Bauer M, Rasgon N, Grof P, Altshuler L, Gyulai L, Lapp M, Glenn T, Whybrow PC. Psychiatry Res. 2005; 133 (1): 73-80
• Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Bauer M, London ED, Rasgon N, Berman SM, Frye MA, Altshuler LL, Mandelkern MA, Bramen J, Voytek B, Woods R, Mazziotta JC, Whybrow PC. Mol Psychiatry. 2005; 10 (5): 456-69
• Adding another spectral dimension to 1H magnetic resonance spectroscopy of hepatic encephalopathy. Binesh N, Huda A, Bugbee M, Gupta R, Rasgon N, Kumar A, Green M, Han S, Thomas MA. J Magn Reson Imaging. 2005; 21 (4): 398-405
• Vitamin E for the treatment of dysmenorrhea. Rasgon NL, Yargin KN. BJOG. 2005; 112 (8): 1164
• Middle-aged children of Alzheimer parents, a pilot study: stable neurocognitive performance at 20-year follow-up. Jarvik LF, La Rue A, Gokhman I, Harrison T, Holt L, Steh B, Harker J, Larson S, Yaralian P, Matsuyama S, Rasgon N, Geschwind D, Freimer N, Jimenez E, Schaeffer J. J Geriatr Psychiatry Neurol. 2005; 18 (4): 187-91
• Does the use of an automated tool for self-reporting mood by patients with bipolar disorder bias the collected data? Bauer M, Rasgon N, Grof P, Gyulai L, Glenn T, Whybrow PC. MedGenMed. 2005; 7 (3): 21
• Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization. Masand PS, Culpepper L, Henderson D, Lee S, Littrell K, Newcomer JW, Rasgon N. CNS Spectr. 2005; 10 (10): suppl14 1-15
• Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis. Rasgon NL, Kenna HA. Neurobiol Aging. 2005: 26 Suppl 1 103-7
• Longitudinal evaluation of reproductive function in women treated for bipolar disorder. Rasgon NL, Reynolds MF, Elman S, Saad M, Frye MA, Bauer M, Altshuler LL. J Affect Disord. 2005; 89 (1-3): 217-25
• Sex-specific self-reported mood changes by patients with bipolar disorder. Rasgon N, Bauer M, Grof P, Gyulai L, Elman S, Glenn T, Whybrow PC. J Psychiatr Res. 2005; 39 (1): 77-83
• Estrogen use and brain metabolic change in postmenopausal women. Rasgon NL, Silverman D, Siddarth P, Miller K, Ercoli LM, Elman S, Lavretsky H, Huang SC, Phelps ME, Small GW. Neurobiol Aging. 2005; 26 (2): 229-35
• Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: a preliminary study. Rasgon NL, Magnusson C, Johansson AL, Pedersen NL, Elman S, Gatz M. Psychoneuroendocrinology. 2005; 30 (6): 558-67
• Reproductive function and risk for PCOS in women treated for bipolar disorder. Rasgon NL, Altshuler LL, Fairbanks L, Elman S, Bitran J, Labarca R, Saad M, Kupka R, Nolen WA, Frye MA, Suppes T, McElroy SL, Keck PE, Leverich G, Grunze H, Walden J, Post R, Mintz J. Bipolar Disord. 2005; 7 (3): 246-59
• Perimenopausal mental disorders: epidemiology and phenomenology. Rasgon N, Shelton S, Halbreich U. CNS Spectr. 2005; 10 (6): 471-8
• Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. Dunkin J, Rasgon N, Wagner-Steh K, David S, Altshuler L, Rapkin A. Psychoneuroendocrinology. 2005; 30 (3): 284-96
• Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report. Becker OV, Rasgon NL, Marsh WK, Glenn T, Ketter TA. Bipolar Disord. 2004; 6 (5): 435-9
• The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. Rasgon N, J Clin Psychopharmacol. 2004; 24 (3): 322-34
• Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. Rasgon N, Jarvik L. J Gerontol A Biol Sci Med Sci. 2004; 59 (2): 178-83; discussion 184-92
• Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study. Bauer M, Fairbanks L, Berghöfer A, Hierholzer J, Bschor T, Baethge C, Rasgon N, Sasse J, Whybrow PC. J Affect Disord. 2004; 83 (2-3): 183-90
• Children of Alzheimer patients: more data needed. Jarvik LF, Harrison TR, Holt L, Jimenez E, Larson SW, LaRue A, Matsuyama SS, Rasgon N, Schaeffer J, Steh B, Yaralian P. J Gerontol A Biol Sci Med Sci. 2004; 59 (10): 1076-7
• The impact of depression and fluoxetine treatment on obstetrical outcome. Suri R, Altshuler L, Hendrick V, Rasgon N, Lee E, Mintz J. Arch Womens Ment Health. 2004; 7 (3): 193-200
• Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder. Bauer M, Grof P, Gyulai L, Rasgon N, Glenn T, Whybrow PC. Bipolar Disord. 2004; 6 (1): 67-74
• Special considerations in treating bipolar disorder in women. Burt VK, Rasgon N. Bipolar Disord. 2004; 6 (1): 2-13
• The electronic assessment of the longitudinal course of bipolar disorder: the ChronoRecord software. Whybrow PC, Grof P, Gyulai L, Rasgon N, Glenn T, Bauer M. Pharmacopsychiatry. 2003: 36 Suppl 3 S244-9
• Menstrual cycle related mood changes in women with bipolar disorder. Rasgon N, Bauer M, Glenn T, Elman S, Whybrow PC. Bipolar Disord. 2003; 5 (1): 48-52
• Emergent oscillations in a mathematical model of the human menstrual cycle. Rasgon NL, Pumphrey L, Prolo P, Elman S, Negrao AB, Licinio J, Garfinkel A. CNS Spectr. 2003; 8 (11): 805-14
• Thyroid, brain and mood modulation in affective disorder: insights from molecular research and functional brain imaging. Bauer M, London ED, Silverman DH, Rasgon N, Kirchheiner J, Whybrow PC. Pharmacopsychiatry. 2003: 36 Suppl 3 S215-21
• Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, Zuckerbrow-Miller J, Korenman SG. J Affect Disord. 2003; 74 (3): 299-304
• Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review. Rasgon NL, Carter MS, Elman S, Bauer M, Love M, Korenman SG. Curr Drug Targets Immune Endocr Metabol Disord. 2002; 2 (1): 97-102
• The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Rapkin AJ, Mikacich JA, Moatakef-Imani B, Rasgon N. Curr Psychiatry Rep. 2002; 4 (6): 419-28
• Mood symptoms and cognitive performance in women estrogen users and nonusers and men. Miller KJ, Conney JC, Rasgon NL, Fairbanks LA, Small GW. J Am Geriatr Soc. 2002; 50 (11): 1826-30
• Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. Rasgon NL, Altshuler LL, Fairbanks LA, Dunkin JJ, Davtyan C, Elman S, Rapkin AJ. J Clin Psychiatry. 2002: 63 Suppl 7 45-8
• Estrogen use and brain metabolic change in older adults. A preliminary report. Rasgon NL, Small GW, Siddarth P, Miller K, Ercoli LM, Bookheimer SY, Lavretsky H, Huang SC, Barrio JR, Phelps ME. Psychiatry Res. 2001; 107 (1): 11-8
• Estrogen-replacement therapy for depression. Rasgon NL, Altshuler LL, Fairbanks L. Am J Psychiatry. 2001; 158 (10): 1738
• Affective disorders and Alzheimer disease: a missing-link hypothesis. Rasgon N, Jarvik GP, Jarvik L. Am J Geriatr Psychiatry. 2001; 9 (4): 444-5
• Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome. Rasgon N, Serra M, Biggio G, Pisu MG, Fairbanks L, Tanavoli S, Rapkin A. Eur J Endocrinol. 2001; 145 (1): 25-33
• Menstrual cycle-related brain metabolite changes using 1H magnetic resonance spectroscopy in premenopausal women: a pilot study. Rasgon NL, Thomas MA, Guze BH, Fairbanks LA, Yue K, Curran JG, Rapkin AJ. Psychiatry Res. 2001; 106 (1): 47-57
• Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder. Suri RA, Altshuler LL, Rasgon NL, Calcagno JL, Frye MA, Gitlin MJ, Hwang S, Zuckerbrow-Miller J. J Clin Psychiatry. 2000; 61 (12): 942-6
• Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. Rasgon NL, Altshuler LL, Gudeman D, Burt VK, Tanavoli S, Hendrick V, Korenman S. J Clin Psychiatry. 2000; 61 (3): 173-8
• Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME. Proc Natl Acad Sci U S A. 2000; 97 (11): 6037-42
• Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome. Rasgon N, McGuire M, Tanavoli S, Fairbanks L, Rapkin A. Fertil Steril. 2000; 73 (1): 144-9
• Toward optimal health: the experts respond to depression. Interview by Jodi Godfrey Meisler. Rasgon N, Nonacs R. J Womens Health Gend Based Med. 1999; 8 (9): 1141-6
• Depressive symptoms in the perimenopause: prevalence, assessment, and guidelines for treatment. Burt VK, Altshuler LL, Rasgon N. Harv Rev Psychiatry. 1998 Sep-Oct; 6 (3): 121-32
• Agenesis of corpus callosum and dementia of the Alzheimer's type: a review and case report. Rasgon N, Ananth J, Mena I, Krout B, Boone K. Can J Psychiatry. 1994; 39 (7): 429-32
• [Alpha-tocopherol induced activation of the endogenous opioid system] Kryzhanovski? GN, Luzina NL, Iarygin KN. Biull Eksp Biol Med. 1989; 108 (11): 566-7
• [The inhibition stage of lipid peroxidation during stress] Guliaeva NV, Luzina NL, Levshina IP, Kryzhanovski? GN. Biull Eksp Biol Med. 1988; 106 (12): 660-3
• [Endogenous opioid system in the realization of the analgesic effect of alpha-tocopherol in reference to algomenorrhea] Kryzhanovski? GN, Bakuleva LP, Luzina NL, Vinogradov VA, Iarygin KN. Biull Eksp Biol Med. 1988; 105 (2): 148-50
• [Use of an antioxidant, alpha-tocopherol acetate, in the complex treatment of algomenorrhea] Luzina NL, Vakuleva LP. Akush Ginekol (Mosk). 1987; (5): 67-9
• [Body reactivity characteristics of chronic salpingo-oophoritis patients at the health resort stage of rehabilitation] Luzina NL, Zelinski? AA, Kryzhanovski? GN. Akush Ginekol (Mosk). 1986; (11): 69-71